Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    The Janus Corner

    The Potential of Cyanobacterial Compounds as Antibiotics

    Web AdminBy Web AdminFebruary 1, 2024Updated:February 16, 2024No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Mitchell Henry Wright* 

    Centre for Planetary Health and Food Security, Nathan Campus, Griffith University, Nathan, AUSTRALIA.

    DOI:10.5530/pc.2024.1.6

    ABSTRACT

    A recent study in Molecules comprehensively reviews cyanobacterial chemistry and the compounds that have antibacterial activity.1 This paper addresses a significant gap in current antimicrobial research by shedding light on the relatively underexplored potential of cyanobacterial compounds as sources of novel antibiotics. In a time when the rise of drug-resistant pathogens presents a significant global health challenge,2 this paper highlights the importance of diversifying the sources of antimicrobial agents, offering fresh perspectives and potential solutions. The authors emphasize the need for further investigation, and encourage continued exploration and highlight priority areas in this promising area of study. This study It not only reviews the known phytochemistry of cyanobacteria, but also provides a thorough evaluation of the effectiveness of these compounds against various types of pathogens, including bacteria, fungi, protozoa, and viruses, thereby broadening the scope of potential applications for cyanobacterial-derived compounds and showcasing their versatility. Furthermore, the emphasis on the safety of these compounds and their potential for drug development is a significant contribution to the field, as it hints at the possibility of developing novel, low-toxicity antimicrobial agents. Overall, this paper is a valuable resource that not only consolidates existing knowledge but also serves as a catalyst for future research in the field of antimicrobial therapies, offering a promising avenue for the discovery of new and effective drugs in the fight against drug-resistant pathogens. 

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up